Evonik has developed an advanced collagen platform that is made via fermentation-based processes and devoid of animal- or human-derived materials. According to the company, the recombinant technology will provide pharmaceutical, medical, cell culture and tissue engineering markets with a highly soluble, ultra-pure form of collagen that is safe, sustainable and commercially scalable. Evonik’s collagen platform features a triple helix structure and other biological properties that mimic m...